Skip to content
Home/Companies/Biotech/AmSilk
AM

AmSilk

Biotech·Germany·Active·18yr hold

AmSilk is a biotech company, headquartered in Germany.

Entry
2008
Hold
18yr
Status
Active
Est. EV
–

Who owns AmSilk?

AmSilk is currently owned by MIG Capital through MIG Fonds 5 (2007 vintage), since 2008. Across its history, AmSilk has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

MIG Capital
Most recent investor
MIG Capital
MIG Fonds 5 · 2007 · Evergreen
2 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by MIG Capital and Athos since 2008.
Co-invest · 2 holders · 2008 · present
MIG Capital
MIG CapitalActive
2008 · present · MIG Fonds 5 · 2007 · Evergreen
MOIC
–
Athos
AthosActive
2025 · present · Athos Evergreen Life Sciences · 2001 · Evergreen
MOIC
–

More from MIG Fonds 5

Other portfolio companies in the same fund.

advanceCOR
Active
BiotechGermany· 2012
Immatics
Active
BiotechGermany· 2010
instrAction
Active
Deep TechGermany· 2008
OD-OS
Active
MedTechGermany· 2008
Ganymed Pharmaceuticals
Exited 2016
BiotechGermany· 2007
to
SuppreMol
Exited 2015
BiotechGermany· 2007
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings